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Inducing Sprouty degradation
 
eceptor tyrosine kinases are often 
regulated by negative feedback loops 
that limit their signaling duration. But 
cells then need to get out of that loop so 
that they can respond once again. One 
way to balance the scales is a “signal-
dependent degradation of a negative 
regulator,” according to Dafna Bar-Sagi.
The inducible degradation of the 
protein hSpry2, a human homologue 
of the negative regulator Sprouty, is the 
subject of two recent articles. In the fly, 
Sprouty is an antagonist of fibroblast and 
epidermal growth factor (FGF and EGF) 
signaling, whereas the human version 
inhibits only FGF signaling. Now, Amy 
Hall, Natalia Jura, Bar-Sagi, and colleagues 
(State University of New York, Stony 
Brook, NY) and Chanan Rubin, Yosef 
Yarden, and colleagues (Weizmann 
Institute, Rehovot, Israel) show that 
when EGF activates its receptor, it also 
triggers degradation of hSpry2.
Both groups demonstrated that EGF 
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Nucleoli come undone
 
he nucleolus is essential for ribosome synthesis, cell cycle 
control, and telomerase sequestration. This complex of 
rDNA, RNA, and proteins disassembles around ovulation 
and later reassembles during early embryogenesis. Somatic 
nuclei transplanted into eggs during nuclear cloning also 
undergo nucleolar disassembly and reassembly—processes 
that may contribute to the low efficiency of nuclear trans-
plantation cloning. Now, Koichi Gonda, Nobuaki Kikyo, and 
colleagues (University of Minnesota, Minneapolis, MN) find 
that, despite their complexity, nucleoli need only a small 
RNA-binding protein to make them fall apart.
Gonda et al. purified two proteins from frog egg cytoplasm, 
T
A nucleolar protein (red) disperses upon addition of FRGY2a (right).
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induced the phosphorylation of hSpry2—
a modification that increased hSpry2’s 
association with the ubiquitin ligase 
c-Cbl. Although ubiquitinated hSpry2 
was then degraded by the proteasome, the 
transient EGF-induced recruitment of 
c-Cbl to hSpry2 prevented the ubiquitin 
ligase from associating with the EGF 
receptor (EGFR). Thus, hSpry2 delayed 
c-Cbl-mediated degradation of EGFR.
As hSpry inhibits FGF signaling, 
this pathway also got a boost from the 
interaction of hSpry2 and c-Cbl. Bar-Sagi’s 
group found that growth factor–induced 
degradation of hSpry2 limited its duration 
as an inhibitor of FGF signaling and 
allowed cells to respond once again to FGF 
stimulation. Interference with the degra-
dation of hSpry2 resulted in sustained 
inhibition of FGF signaling.
Although both stories highlight the 
inducible c-Cbl–regulated degradation of 
hSpry2, it is not clear how hSpry2 inhibits 
FGFR before hSpry2 is degraded, or why 
this activity is lost from the EGFR cascade 
in human cells. 
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EGF (lower panel) stimulates the associ-
ation of hSpry2 (green) with c-Cbl (red) 
and hSpry2 degradation.
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FRGY2a and FRGY2b, that have nucleolar disassembly 
activity. Recombinant versions of either protein dispersed 
nucleolar proteins and RNA, leaving only small nucleolar 
remnants. FRGY2a/b may release proteins bound to RNA 
within the nucleoli through nonspecific competition, as 
regions imparting nonselective charge interactions with RNA 
were necessary for disassembly. Alternatively, they may 
target specific RNAs or RNA-protein particles, such as 
preribosomes. The latter argument is supported by the fact 
that mammalian nucleoli were not disassembled in frog eggs, 
although FRGY homologues have been identified in mouse 
and human cells.
The findings offer a simple biochemical method for studying 
nuclear remodeling during cloning as well as nucleolar 
assembly in general. The identification of RNAs or proteins 
that interact with FRGY2a/b should point to components 
necessary to maintain nucleoli. Nucleoli harbor certain 
cancer- and aging-related proteins, including p53-binding 
proteins and telomerase. “If we can understand how these 
proteins are localized or released by certain stimuli, we 
may be able to modify their localization for therapeutic ap-
plications,” says Kikyo.
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